{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:30:49Z","timestamp":1768455049018,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.amjmed.2009.09.042","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T04:20:21Z","timestamp":1275711621000},"page":"489-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Caring for the Breast Cancer Survivor: A Guide for Primary Care Physicians"],"prefix":"10.1016","volume":"123","author":[{"given":"Pavani","family":"Chalasani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison T.","family":"Stopeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjmed.2009.09.042_bib1","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.amjmed.2009.09.042_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.suronc.2006.11.003","article-title":"Lymphedema following axillary lymph node dissection for breast cancer","volume":"15","author":"Sakorafas","year":"2006","journal-title":"Surg Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2008.17.9291","article-title":"Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms","volume":"27","author":"Norman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib6","series-title":"Diseases of the breast","author":"Petrek","year":"2004"},{"issue":"1","key":"10.1016\/j.amjmed.2009.09.042_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1040-8428(03)00097-0","article-title":"Follow-up care of breast cancer survivors","volume":"48","author":"Hurria","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.amjmed.2009.09.042_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(20010815)92:4<748::AID-CNCR1378>3.0.CO;2-V","article-title":"Lymphedema after sentinel lymphadenectomy for breast carcinoma","volume":"92","author":"Sener","year":"2001","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.amjmed.2009.09.042_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJM200010123431506","article-title":"Primary care for survivors of breast cancer","volume":"343","author":"Burnstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.042_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1259\/bjr\/61567884","article-title":"Imaging breast augmentation and reconstruction","volume":"81","author":"Glynn","year":"2008","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.amjmed.2009.09.042_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiology.206.1.9423681","article-title":"Fat necrosis in the breast: sonographic features","volume":"206","author":"Soo","year":"1998","journal-title":"Radiology"},{"issue":"32","key":"10.1016\/j.amjmed.2009.09.042_bib13","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1200\/JCO.2007.15.7123","article-title":"Tamoxifen use and osteoporotic fracture risk: a population-based analysis","volume":"26","author":"Cooke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9453","key":"10.1016\/j.amjmed.2009.09.042_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2009.09.042_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after 2 to 3 years of tamoxifen in post menopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.042_bib16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole after 5 years of tamoxifen in post menopausal women with early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.042_bib17","first-page":"87","article-title":"Updated analysis of NCIC CTG MA.17 randomized placebo controlled trial of letrozole after 5 years of tamoxifen in post menopausal women with early stage breast cancer [abstract 847]","volume":"23","author":"Goss","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjmed.2009.09.042_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1200\/JCO.2005.05.3744","article-title":"Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer","volume":"25","author":"Brufsky","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjmed.2009.09.042_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cncr.23259","article-title":"Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST study results","volume":"112","author":"Bundred","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.amjmed.2009.09.042_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.042_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.gme.0000243566.25205.0b","article-title":"The role of calcium in peri- and postmenopausal women: 2006 position statement of The North American Menopause Society","volume":"13","year":"2006","journal-title":"Menopause"},{"issue":"21","key":"10.1016\/j.amjmed.2009.09.042_bib23","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1933719108327595","article-title":"Vitamin D acquisition and breast cancer risk","volume":"16","author":"P\u00e9rez-L\u00f3pez","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.amjmed.2009.09.042_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1634\/theoncologist.2008-0112","article-title":"Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer","volume":"13","author":"Lenihan","year":"2008","journal-title":"Oncologist"},{"issue":"30","key":"10.1016\/j.amjmed.2009.09.042_bib26","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1200\/JCO.2005.13.755","article-title":"Cardiac morbidity of adjuvant radiotherapy for breast cancer","volume":"23","author":"Patt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/107327480801500204","article-title":"Cardiac mortality and morbidity after breast cancer treatment","volume":"15","author":"Harris","year":"2008","journal-title":"Cancer Control"},{"key":"10.1016\/j.amjmed.2009.09.042_bib28","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","article-title":"Early and delayed clinical cardiotoxicity of doxorubicin","volume":"55","author":"Buzdar","year":"1985","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.amjmed.2009.09.042_bib29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","article-title":"Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer","volume":"21","author":"Henderson","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjmed.2009.09.042_bib30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/annonc\/mdn739","article-title":"Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer","volume":"20","author":"Buzdar","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-115-11-860","article-title":"Effects of tamoxifen on cardiovascular risk factors in postmenopausal women","volume":"115","author":"Love","year":"1991","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.amjmed.2009.09.042_bib33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","article-title":"Meta-analysis of vascular and neoplastic events associated with tamoxifen","volume":"18","author":"Braithwaite","year":"2003","journal-title":"J Gen Intern Med"},{"issue":"36","key":"10.1016\/j.amjmed.2009.09.042_bib34","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1200\/JCO.2007.12.1665","article-title":"Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial","volume":"25","author":"Mouridsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/annonc\/mdi158","article-title":"The influence of letrazole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA 17L)","volume":"16","author":"Wasan","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BID 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib37","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.1998.16.6.2018","article-title":"Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes","volume":"16","author":"Ragaz","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib38","first-page":"288","article-title":"; Writing Group for the Women's Health Initiative Investigators","author":"Rossouw JE Anderson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.09.042_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjmed.2009.09.042_bib40","first-page":"9","article-title":"Menopausal symptoms: alternatives to hormone replacement therapy (HRT)","volume":"13","author":"Chalasani","year":"2008","journal-title":"Ariz Geriatr Soc"},{"issue":"1","key":"10.1016\/j.amjmed.2009.09.042_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-006-9428-0","article-title":"The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen","volume":"101","author":"Goetz","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjmed.2009.09.042_bib42","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","article-title":"Annual hazard rates of recurrence for breast cancer after primary therapy","volume":"14","author":"Saphner","year":"1996","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.amjmed.2009.09.042_bib43","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1200\/JCO.2006.08.8575","article-title":"American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting","volume":"24","author":"Klatcheressian","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjmed.2009.09.042_bib44","article-title":"Follow-up strategies for women treated for early breast cancer","volume":"225","author":"Rojas","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2009.09.042_bib45","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjmed.2009.09.042_bib47","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199206253262605","article-title":"Risk of leukemia after chemotherapy and radiation treatment for breast cancer","volume":"326","author":"Curtis","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.042_bib48","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1200\/JCO.2005.05.029","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide","volume":"23","author":"Praga","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2009.09.042_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3816\/CBC.2003.n.032","article-title":"Risk for the development of treatment-related leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience","volume":"4","author":"Smith","year":"2003","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.amjmed.2009.09.042_bib50","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2301::AID-CNCR1>3.0.CO;2-A","article-title":"Pregnancy after breast carcinoma: the ultimate medical challenge","volume":"85","author":"Averette","year":"1999","journal-title":"Cancer"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:53:12Z","timestamp":1757580792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0002934310001270"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.09.042","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caring for the Breast Cancer Survivor: A Guide for Primary Care Physicians","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}